glp 1 vs sglt2 cardioprotective effects Diabetic Agents, From Metformin to Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar GLP-1 Agonists in Cardiovascular Diseases:

Such monitoring may include assessment of dietary protein intake, body composition trajectories, and micronutrient status in order to maintain proportionality between oxidative metabolic demand and substrate-supported regenerative capacity This perspective aligns with emerging calls to integrate pharmacologic and nutritional paradigms in obesity treatment, recognizing that durable metabolic adaptation requires coordination between drug-mediated signaling effects and substrate-dependent metabolic processes [103, 115]

It works through neurological pathways involved in sexual desire and arousal

PMID 29088702

Cognitive Health and Neuroprotection